BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 25556717)

  • 21. Functional immunoglobulin E cross-reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens.
    Davies JM; Dang TD; Voskamp A; Drew AC; Biondo M; Phung M; Upham JW; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2011 Feb; 41(2):281-91. PubMed ID: 21231976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
    Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
    Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total transcriptome, proteome, and allergome of Johnson grass pollen, which is important for allergic rhinitis in subtropical regions.
    Campbell BC; Gilding EK; Timbrell V; Guru P; Loo D; Zennaro D; Mari A; Solley G; Hill MM; Godwin ID; Davies JM
    J Allergy Clin Immunol; 2015 Jan; 135(1):133-42. PubMed ID: 25129679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of macrophages in the initiation of allergic rhinitis in mice sensitized intranasally once with cedar pollen: regulation of class switching of immunoglobulin in B cells by controlling interleukin-4 production in T cells of submandibular lymph nodes.
    Hirano M; Ogita-Nakanishi H; Miyachi W; Hannya N; Yamamoto-Kimoto Y; Sakurai K; Miyoshi-Higashino M; Tashiro-Yamaji J; Kato R; Ijiri Y; Tanaka K; Kanazawa A; Terada T; Kawata R; Takenaka H; Kubota T; Yoshida R
    Microbiol Immunol; 2012 Jun; 56(6):392-405. PubMed ID: 22404751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
    Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
    EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.
    Hinz D; Seumois G; Gholami AM; Greenbaum JA; Lane J; White B; Broide DH; Schulten V; Sidney J; Bakhru P; Oseroff C; Wambre E; James EA; Kwok WW; Peters B; Vijayanand P; Sette A
    Clin Exp Allergy; 2016 May; 46(5):705-19. PubMed ID: 26662458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
    Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigens drive memory IgE responses in human allergy via the nasal mucosa.
    Niederberger V; Ring J; Rakoski J; Jager S; Spitzauer S; Valent P; Horak F; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2007; 142(2):133-44. PubMed ID: 17057411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.
    Qaseem AS; Singh I; Pathan AA; Layhadi JA; Parkin R; Alexandra F; Durham SR; Kishore U; Shamji MH
    Am J Respir Crit Care Med; 2017 Dec; 196(12):1526-1534. PubMed ID: 28915062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
    Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
    Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
    Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
    Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
    Focke-Tejkl M; Weber M; Niespodziana K; Neubauer A; Huber H; Henning R; Stegfellner G; Maderegger B; Hauer M; Stolz F; Niederberger V; Marth K; Eckl-Dorna J; Weiss R; Thalhamer J; Blatt K; Valent P; Valenta R
    J Allergy Clin Immunol; 2015 May; 135(5):1207-7.e1-11. PubMed ID: 25441634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Component-resolved diagnosis of baker's allergy based on specific IgE to recombinant wheat flour proteins.
    Sander I; Rihs HP; Doekes G; Quirce S; Krop E; Rozynek P; van Kampen V; Merget R; Meurer U; Brüning T; Raulf M
    J Allergy Clin Immunol; 2015 Jun; 135(6):1529-37. PubMed ID: 25576081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal allergen-neutralizing IgG
    Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen-specific IgG
    Hoof I; Schulten V; Layhadi JA; Stranzl T; Christensen LH; Herrera de la Mata S; Seumois G; Vijayanand P; Lundegaard C; Niss K; Lund A; Ahrenfeldt J; Holm J; Steveling E; Sharif H; Durham SR; Peters B; Shamji MH; Andersen PS
    J Allergy Clin Immunol; 2020 Jul; 146(1):180-191. PubMed ID: 31883847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.